Handbook of Experimental Pharmacology - Part 9 doc
Handbook of Experimental Pharmacology - Part 9 doc
... symaptho-vagal balance in favor of the development of an arrhythmo-
genic substrate (Litovsky and Antzelevitch 199 0; Yan and Antzelevitch 199 9).
Therapy for the Brugada Syndrome 307
Fig. 1 Twelve-lead ... (2002) Increased risk of arrh ythmic events in long-QT
syndrome wi th mutations in the pore region of the human ether-a-go-go-related gene
potassium channel. Circulation 105: 794 –...
Handbook of Experimental Pharmacology - Part 1 docx
... 66: 498 508
Janse MJ ( 196 9) Inuence of the direction of the atrial wavefront on A-V nodal transmission
in isolated hearts of rabbits. Circ Res 25:4 394 49
30 M.J . Janse · M.R. Rosen
In the setting of ... family as the molecular correlate of I
f
(Biel et al. 199 9; Santoro and
T ibbs 199 9) allows the use of transgenic technology to suppress expression of
specific HCN isoforms...
Handbook of Experimental Pharmacology - Part 4 doc
... 199 8), regulation
by extern al K
+
(Abbott et al. 199 9; McDonald et al. 199 7; Shibasaki 198 7), and
sensitivity to antiarrhythmics (Sanguinetti et al. 199 5). These data suggest the
presence of ... J
106:8 29 8 39
Rosen MR, Wit AL ( 198 7) Arrhythmogenic actions of antiarrh ythmic drugs. Am J Cardiol
59: E10–E18
Rosen MR, Hoffman BF, Wit AL ( 197 5) Electrophysiology and pharmacolog...
Handbook of Experimental Pharmacology Volume 168 docx
... 199 6
1-Deoxy-11-hydroxy- 1.2
c
0.032 Huffman et al. 199 6
∆
8
-THC-DMH (JWH-051)
JTE -9 0 7 2,370 35 .9 Iwamura et al. 2001
L-768242 1 ,91 7 12 Gallant et al. 199 6
3-( 1
1
-dimethylpropyl )- 2, 290
c
14 ... 199 9
1-deoxy-
∆
8
-THC (JWH-1 39)
3-( 1
1
-dimethylhexyl )- 3,134
c
18 Huffman et al. 2002
1-methoxy-
∆
8
-THC
1-Deoxy-
∆
8
-THC >10,000
c
32 Huffman et al. 19...
Handbook of Economic Forecasting part 9 docx
... 195 9:1 through 198 1:4 was the
base estimation period, followed by 20 successive five-year experimental forecasts: the
first was for 198 2:1 through 198 6:4; and the last was for 198 6:4 through 199 1:3 ... 3
Comparison of forecast RMSE in Shoesmith ( 199 5)
Horizon
1 quarter 8 quarters 20 quarters
VA R/I1 1 .33 1.00 1.14
ECM 1.28 0. 89 0 .91
BVAR/I1 0 .97 0 .96 0.85
BECM 0. 89 0.72 0.4...
HANDBOOK OF PSYCHIATRIC DRUGS - PART 9 docx
... option for treatment of opioid with-
drawal is the schedule III opioid partial agonist buprenor-
phine, which is now available for use in office-based practice
230
HANDBOOK OF PSYCHIATRIC DRUGS
these ... depth.
HandbookofPsychiatricDrugsJeffreyA.LiebermanandAllanTasman
©2006JohnWiley&Sons,Ltd. ISBN: 0-4 7 0-0 282 1-1
216
HANDBOOK OF PSYCHIATRIC DRUGS
SYNDROMES ASSOCIATED...
Handbook of sexual dysfunction - part 9 docx
... 294
Prevalence 295
Gender and the Paraphilias 296
Comorbidity 297
The DSM-IV-TR Listed Paraphilias 298
Voyeurism, Exhibitionism, and Frotteurism 298
Voyeurism 298
Exhibitionism 298
Frotteurism ... Paris, 2004 :93 2. ISBN 0 -9 54 695 6-0 -7 .
3. Reissing ED, Binik YM, Khalife
´
S, Cohen D, Amsel MA. Etiological correlates of
vaginismus: sexual and physical abuse, sexual knowledge...
Handbook of Experimental Pharmacology - Part 1 pps
... Tables
ISSN 017 1-2 004
ISBN-10 3-5 4 0-2 496 7-2 Springer Berlin Heidelberg New York
ISBN-13 97 8-3 -5 4 0-2 496 7-2 Springer Berlin Heidelberg New York
Library of Congress Control Number: 200 592 5472
This work ... a single re-entrant circuit (Cox et al. 199 1;
Konings et al. 199 4) at “such a high rate that that it cannot be followed in a 1:1
fashion by all parts of the...
Handbook of Experimental Pharmacology - Part 3 pdf
... 199 8;
Choy et al. 199 9
Congestive heart failure Torp-Pedersen et al. 199 9
Digitalis therapy Houltz et al. 199 8
Subclinical congenital long QT syndrome Donger et al. 199 7; Napolitano et al. 199 7,
2000; ... GR, Roden DM ( 199 9) Inhibition of P-glyco-
protein-mediated drug transport: a unifying mechanism to explain the interaction be-
tween digoxin and quinidine. Circulation 99 :552–55...
Handbook of Experimental Pharmacology - Part 5 ppsx
... delayed rectifier potassium current IKs by (R )-2 -( 2,4-trifluoromethyl)-N-[2-oxo- 5-
phenyl- 1-( 2,2,2-trifluoroethyl )-2 , 3-dihydro-1H-benzo[e][1,4]diazepin-3-yl]acetamide.
J Med Chem 40:3865–3868
Sesti ... totheshortQT-interval syndrome.
Circulation 1 09: 2 394 –2 397
Berube J, Chahine M, Daleau P ( 199 9) M odulation of HERG potassium channel properties
by external pH. Pflugers...
Từ khóa: